Initial experience with the subcutaneous implantable cardioverter-defibrillator in a single Japanese center

Nobuhiro Nishii, Motomi Tachibana, Yoshimasa Morimoto, Satoshi Kawada, Akihito Miyoshi, Hiroyasu Sugiyama, Koji Nakagawa, Atsuyuki Watanabe, Kazufumi Nakamura, Hiroshi Morita, Hiroshi Ito

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Background: The subcutaneous implantable cardioverter-defibrillator (S-ICD) is recognized as a viable alternative to the transvenous ICD. The safety and efficacy of this device has been demonstrated in Western countries, but studies with S-ICD implantation in Japanese patients have not been reported. Methods and results: Twelve patients received an S-ICD implant in our institute between February and September 2016. All S-ICDs were successfully implanted without complications. One appropriate and one inappropriate therapy was identified. Conclusions: S-ICD implantation appears to provide a viable alternative to transvenous ICD implantation for some Japanese patients. However, we should perform careful follow-up of patients to eliminate inappropriate therapy.

Original languageEnglish
JournalJournal of Arrhythmia
DOIs
Publication statusAccepted/In press - Dec 6 2016

Fingerprint

Implantable Defibrillators
Protective Devices
Therapeutics

Keywords

  • Subcutaneous implantable cardioverter-defibrillator
  • Sudden cardiac death
  • T-wave oversensing

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

@article{c0bae7d6f3a34c839f951843e2b65bfa,
title = "Initial experience with the subcutaneous implantable cardioverter-defibrillator in a single Japanese center",
abstract = "Background: The subcutaneous implantable cardioverter-defibrillator (S-ICD) is recognized as a viable alternative to the transvenous ICD. The safety and efficacy of this device has been demonstrated in Western countries, but studies with S-ICD implantation in Japanese patients have not been reported. Methods and results: Twelve patients received an S-ICD implant in our institute between February and September 2016. All S-ICDs were successfully implanted without complications. One appropriate and one inappropriate therapy was identified. Conclusions: S-ICD implantation appears to provide a viable alternative to transvenous ICD implantation for some Japanese patients. However, we should perform careful follow-up of patients to eliminate inappropriate therapy.",
keywords = "Subcutaneous implantable cardioverter-defibrillator, Sudden cardiac death, T-wave oversensing",
author = "Nobuhiro Nishii and Motomi Tachibana and Yoshimasa Morimoto and Satoshi Kawada and Akihito Miyoshi and Hiroyasu Sugiyama and Koji Nakagawa and Atsuyuki Watanabe and Kazufumi Nakamura and Hiroshi Morita and Hiroshi Ito",
year = "2016",
month = "12",
day = "6",
doi = "10.1016/j.joa.2017.02.004",
language = "English",
journal = "Journal of Arrhythmia",
issn = "1880-4276",
publisher = "Elsevier BV",

}

TY - JOUR

T1 - Initial experience with the subcutaneous implantable cardioverter-defibrillator in a single Japanese center

AU - Nishii, Nobuhiro

AU - Tachibana, Motomi

AU - Morimoto, Yoshimasa

AU - Kawada, Satoshi

AU - Miyoshi, Akihito

AU - Sugiyama, Hiroyasu

AU - Nakagawa, Koji

AU - Watanabe, Atsuyuki

AU - Nakamura, Kazufumi

AU - Morita, Hiroshi

AU - Ito, Hiroshi

PY - 2016/12/6

Y1 - 2016/12/6

N2 - Background: The subcutaneous implantable cardioverter-defibrillator (S-ICD) is recognized as a viable alternative to the transvenous ICD. The safety and efficacy of this device has been demonstrated in Western countries, but studies with S-ICD implantation in Japanese patients have not been reported. Methods and results: Twelve patients received an S-ICD implant in our institute between February and September 2016. All S-ICDs were successfully implanted without complications. One appropriate and one inappropriate therapy was identified. Conclusions: S-ICD implantation appears to provide a viable alternative to transvenous ICD implantation for some Japanese patients. However, we should perform careful follow-up of patients to eliminate inappropriate therapy.

AB - Background: The subcutaneous implantable cardioverter-defibrillator (S-ICD) is recognized as a viable alternative to the transvenous ICD. The safety and efficacy of this device has been demonstrated in Western countries, but studies with S-ICD implantation in Japanese patients have not been reported. Methods and results: Twelve patients received an S-ICD implant in our institute between February and September 2016. All S-ICDs were successfully implanted without complications. One appropriate and one inappropriate therapy was identified. Conclusions: S-ICD implantation appears to provide a viable alternative to transvenous ICD implantation for some Japanese patients. However, we should perform careful follow-up of patients to eliminate inappropriate therapy.

KW - Subcutaneous implantable cardioverter-defibrillator

KW - Sudden cardiac death

KW - T-wave oversensing

UR - http://www.scopus.com/inward/record.url?scp=85016399363&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85016399363&partnerID=8YFLogxK

U2 - 10.1016/j.joa.2017.02.004

DO - 10.1016/j.joa.2017.02.004

M3 - Article

AN - SCOPUS:85016399363

JO - Journal of Arrhythmia

JF - Journal of Arrhythmia

SN - 1880-4276

ER -